Hexagon Nutrition IPO
Get the latest Hexagon Nutrition IPO details, including issue information, financial performance, business overview, strengths, risks, promoters, GMP updates, subscription status, allotment, listing details, and expert IPO analysis.
Hexagon Nutrition IPO Details
Hexagon Nutrition IPO bidding started from Jun 5, 2026 and ended on Jun 9, 2026. The allotment for Hexagon Nutrition IPO was finalized on Jun 10, 2026. The shares got listed on NSE and BSE on Jun 12, 2026.
Hexagon Nutrition IPO Timeline (Tentative)
The IPO timeline provides the important milestones associated with the Hexagon Nutrition IPO, including the issue opening and closing dates, basis of allotment, initiation of refunds, credit of shares to investors' demat accounts, and the proposed listing date. Investors should monitor these dates to stay informed about the progress of the public issue. Final dates will be updated once officially announced.
| Event | Tentative Date |
|---|---|
| IPO Open Date | Fri, Jun 5, 2026 |
| IPO Close Date | Tue, Jun 9, 2026 |
| Basis of Allotment | Wed, Jun 10, 2026 |
| Initiation of Refunds | Thu, Jun 11, 2026 |
| Credit of Shares to Demat | Thu, Jun 11, 2026 |
| Listing Date | Fri, Jun 12, 2026 |
| IPO Open | Jun 5, 2026 |
| IPO Close | Jun 9, 2026 |
| Allotment | Jun 10, 2026 |
| Refund | Jun 11, 2026 |
| Credit of Shares | Jun 11, 2026 |
| Listing | Jun 12, 2026 |
Hexagon Nutrition IPO Lot Size
The lot size determines the minimum number of equity shares that investors must apply for in the IPO. It also indicates the minimum investment required for retail applicants and the application limits for different investor categories. The final lot size and investment amounts will be available once the IPO price band is announced.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 333 | 14,985 |
| Retail (Max) | 13 | 4,329 | 1,94,805 |
| S-HNI (Min) | 14 | 4,662 | 2,09,790 |
| S-HNI (Max) | 66 | 21,978 | 9,89,010 |
| B-HNI (Min) | 67 | 22,311 | 10,03,995 |
Hexagon Nutrition IPO Reservation
Hexagon Nutrition IPO comprises a total issue size of 3,08,59,704 shares. Out of which, 1,54,29,851 (50.00%) are allocated to QIB, 46,28,956 (15.00%) allocated to NII 1,08,00,897 (35.00%) allocated to RII.
About Hexagon Nutrition
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.
Its product portfolio is classified into three segments:
- Branded wellness and clinical nutrition products (B2C)
- Premix formulations (B2B2C)
- Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives
Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.
The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.
Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Strengths
- Established player in the nutrition and wellness industry with operations dating back to 1993.
- Diversified product portfolio covering clinical nutrition, micronutrient premixes, food fortification, and wellness products.
- Strong research and development capabilities supporting product innovation.
- Presence in both domestic and international markets through subsidiaries and exports.
- Well-recognized brands including Pentasure and Nutrone.
- Multiple manufacturing facilities with integrated production capabilities.
- Long-standing relationships with institutional, healthcare, and export customers.
- Strategy focused on expanding into new nutrition categories and strengthening the domestic market while maintaining export growth.
Risks to Consider
- Business performance depends on demand for nutrition and wellness products across domestic and export markets.
- A significant portion of revenue has historically been derived from exports, exposing the company to international market risks.
- Fluctuations in raw material prices may affect operating margins.
- The company is involved in certain ongoing legal and regulatory proceedings, and adverse outcomes could impact its financial condition or reputation.
- The nutrition industry is highly competitive, requiring continuous product innovation and regulatory compliance.
- Changes in healthcare regulations, food safety standards, or consumer preferences may affect future operations.
Hexagon Nutrition Financials (₹ Cr)
The financial information section presents the key financial highlights of Hexagon Nutrition Limited, including revenue, profit after tax, total assets, and net worth for the reported financial periods. These figures help investors evaluate the company's growth, profitability, and overall financial position before making an investment decision. The company has reported steady operations across its nutrition and wellness businesses and continues to expand its domestic and international presence.
| Period | Revenue | PAT | Total Assets | Net Worth |
|---|---|---|---|---|
| FY2025 | ₹... | ₹... | ₹... | ₹... |
| FY2024 | ₹... | ₹... | ₹... | ₹... |
| FY2023 | ₹... | ₹... | ₹... | ₹... |
KPIs & Valuation
Key Performance Indicators (KPIs) and valuation metrics enable investors to assess Hexagon Nutrition's operational efficiency, profitability, capital structure, and overall financial performance. These indicators include measures such as Return on Equity (RoE), Return on Net Worth (RoNW), EBITDA Margin, PAT Margin, Earnings Per Share (EPS), Net Asset Value (NAV), and other valuation ratios disclosed in the offer documents.Period
Objects of the Issue
The Red Herring Prospectus explains the purpose of the public issue and how the proceeds are proposed to be utilized. Investors should review these objectives carefully to understand how the company intends to deploy the funds raised through the IPO and how they align with its long-term growth strategy.
- Funding capital expenditure for expansion and modernization of manufacturing facilities.
- Supporting the company's working capital requirements.
- Repayment or prepayment of certain borrowings, where applicable.
- Investment in subsidiaries and business expansion initiatives, where required.
- Strengthening research and development capabilities and product innovation.
- Meeting general corporate purposes in accordance with applicable laws.
Promoters, Lead Managers & Registrar
The Promoters, Book Running Lead Managers (BRLMs), and Registrar play important roles in the IPO process. The promoters are responsible for the company's overall strategic direction and long-term growth, while the BRLMs manage the public issue, coordinate regulatory compliance, and assist with marketing the offering. The Registrar oversees the IPO application process, basis of allotment, refunds, and credit of equity shares to investors' demat accounts. The details of these entities help investors understand the key participants involved in the successful execution of the IPO.
Promoters
Lead Managers (BRLM)
Hexagon Nutrition IPO Review
Hexagon Nutrition Limited has built a long-standing presence in the nutrition and wellness industry with a diversified portfolio of clinical nutrition, micronutrient premixes, food fortification solutions, and consumer wellness products. The company benefits from established brands, multiple manufacturing facilities, research and development capabilities, and a growing international footprint.
Its diversified customer base, export presence, and focus on innovation provide opportunities for long-term growth. However, investors should also consider factors such as industry competition, raw material price fluctuations, regulatory compliance, and dependence on domestic and international market demand before making an investment decision.
As with any IPO, investment decisions should be based on the company's financial performance, valuation, risk factors, and individual investment objectives rather than market sentiment alone.
How to Apply
You can apply for the Hexagon Nutrition IPO through any of the following methods:
- Log in to your internet banking account and use the ASBA (Application Supported by Blocked Amount) facility offered by your bank.
- Apply through your stockbroker using the UPI-based IPO application process if you are a retail investor.
- Enter the required IPO details, including the bid price, bid quantity, and investor information.
- Approve the UPI mandate or complete the ASBA authorization within the prescribed timeline.
- Submit your application before the IPO closing date and keep the application reference for future tracking.
- After the basis of allotment is finalized, successful applicants will receive shares in their demat accounts, while funds for unsuccessful or partially successful applications will be released in accordance with the applicable process.
Last updated Aug 6, 2026.